EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epigenome and transcriptome changes in KMT2D-related Kabuki syndrome Type 1 iPSCs, neuronal progenitors and cortical neurons

Sara Cuvertino iD, Evgenii Martirosian iD, Kedar Bhosale iD, Peiwen Cheng iD, Terence Garner, Ian J Donaldson, Adam Jackson, Adam Stevens, Andrew D Sharrocks, Susan J Kimber iD, Siddharth Banka iD

PLOS Genetics · 19.09.2025 · 21 (9) · e1011608

DOI: 10.1371/journal.pgen.1011608 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Genetics, online erschienen am 19.09.2025. Verfasst von Sara Cuvertino und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester,…. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Vestibular Diseases, Transcriptome, DNA-Binding Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Great Ormond Street Hospital Charity, Newlife the Charity for Disabled Children.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kabuki syndrome type 1 (KS1) is a neurodevelopmental disorder caused by loss-of-function variants in KMT2D which encodes a H3K4 methyltransferase. The mechanisms underlying neurodevelopmental problems in KS1 are still largely unknown. Here, we track the epigenome and transcriptome across three stages of neuronal differentiation using patient-derived induced pluripotent stem cells (iPSCs) to gain insights into the disease mechanism of KS1. In KS1 iPSCs we detected significantly lower levels of functional KMT2D transcript and KMT2D protein, and lower global H3K4me1, H3K4me2 levels and modest reduction in H3K4me3. We identify loss of thousands of H3K4me1 peaks in iPSCs, neuronal progenitors (NPs) and early cortical neurons (CNs) in KS1. We show that the number of lost peaks increase as differentiation progresses. We also identify hundreds of differentially expressed genes (DEGs) in iPSCs, NPs and CNs in KS1. In contrast with the epigenomic changes, the number of DEGs decrease as differentiation progresses. Our analysis reveals significant enrichment of differentially downregulated genes in areas containing putative enhancer regions with H3K4me1 loss. We also identify a set of distinct transcription factor binding sites in differentially methylated regions and a set of DEGs related to KS1 phenotypes. We find that genes regulated by SUZ12, a subunit of Polycomb Repressive complex 2, are over-represented in KS1 DEGs at early stages of differentiation. In conclusion, we present a disease-relevant human cellular model for KS1 that provides mechanistic insights for the disorder and could be used for high throughput drug screening for KS1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsVestibular DiseasesTranscriptomeDNA-Binding ProteinsHematologic DiseasesAbnormalities, MultipleFaceEpigenomeNeoplasm ProteinsHumansNeuronsNeural Stem CellsCell DifferentiationHistonesEpigenesis, Genetic

Substanzen

KMT2D protein, humanDNA-Binding ProteinsNeoplasm ProteinsHistones

Autor:innen und Institutionen

  • Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester, United Kingdom.
  • Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester, United Kingdom.
  • Division of Developmental Biology & Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester, United Kingdom.
  • Bioinformatics Core Facility, The University of Manchester, Manchester, United Kingdom.
  • Manchester Centre for Genomic Medicine, St. Mary's Hospital, Manchester University Foundation NHS Trust, Health Innovation Manchester, Manchester, United Kingdom.
  • Division of Molecular and Cellular Function, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.

ORCID-Profile: Sara Cuvertino, Evgenii Martirosian, Kedar Bhosale, Peiwen Cheng, Susan J Kimber, Siddharth Banka

Förderung

  • Wellcome Trust
  • Great Ormond Street Hospital Charity
  • Newlife the Charity for Disabled Children
  • Manchester University NHS Foundation Trust Kabuki Research Fund
  • Manchester Biomedical Research Centre
  • MRC Epigenomics of Rare Diseases Node
  • Engineering and Physical Sciences Research Council

Zitieren

APA

Cuvertino, S., Martirosian, E., Bhosale, K., Cheng, P., Garner, T., Donaldson, I. J., Jackson, A., Stevens, A., Sharrocks, A. D., Kimber, S. J., & Banka, S. (2025). Epigenome and transcriptome changes in KMT2D-related Kabuki syndrome Type 1 iPSCs, neuronal progenitors and cortical neurons. PLOS Genetics, 21(9), e1011608. https://doi.org/10.1371/journal.pgen.1011608

Vancouver

Cuvertino S, Martirosian E, Bhosale K, Cheng P, Garner T, Donaldson IJ, et al. Epigenome and transcriptome changes in KMT2D-related Kabuki syndrome Type 1 iPSCs, neuronal progenitors and cortical neurons. PLOS Genetics. 2025;21(9):e1011608. doi:10.1371/journal.pgen.1011608

BibTeX
@article{Cuvertino2025,
  author = {Cuvertino, Sara and Martirosian, Evgenii and Bhosale, Kedar and Cheng, Peiwen and Garner, Terence and Donaldson, Ian J and Jackson, Adam and Stevens, Adam and Sharrocks, Andrew D and Kimber, Susan J and Banka, Siddharth},
  title = {Epigenome and transcriptome changes in KMT2D-related Kabuki syndrome Type 1 iPSCs, neuronal progenitors and cortical neurons},
  journal = {PLOS Genetics},
  year = {2025},
  volume = {21},
  number = {9},
  pages = {e1011608},
  doi = {10.1371/journal.pgen.1011608}
}
Kostenlos starten →